Predicine
PrivateLast Round
Series B
Jul 29, 2020
Total Funding Raised
$37.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Predicine is a biotechnology company that develops a cell-free DNA- and cell-free RNA-based liquid biopsy technology for cancer diagnostics and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Clinical Trials, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Predicine Comparables
Compare Predicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucence | 85% | |
| DiaCarta, Inc. | 83% | |
| Precede Biosciences | 82% | |
Predicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2020 | ||||
| Series A | Apr 16, 2018 | ||||
| Pre Seed | May 15, 2017 |
Predicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Series B, Series A |
| Highlight Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased by 45% MoM.
- Jun 21, 2026
Monthly visitors grew 250% MoM, reaching 2.5K.
Predicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Predicine's valuation, stock price, and market status.